Post hoc analysis of 4267 symptomatic outpatients without known CAD who had CCTA in PROMISE: total and noncalcified plaque burden independently predicted MACE (aHR 1.18 and 1.20); TPV of 87 mm3 or more was linked to about double the risk (aHR 2.07).
Secondary analysisn = 4,267
Karády et al. Prognostic Value of Plaque Volume in Patients With First Diagnosis of Coronary Artery Disease: A Substudy of the PROMISE Randomized Clinical Trial